Zydus Lifesciences JV to Invest USD 20 Million in Sri Lanka Manufacturing Facility
Zydus Lifesciences Ltd 路 Press Release 路 15 Oct 2026, 5:01 pm
Zydus Lifesciences JV to Invest USD 20 Million in Sri Lanka Manufacturing Facility Zydus Sunshine Lifesciences (Pvt) Ltd, a JV between Zydus Lifesciences and Sunshine Healthcare (part of Sunshine Holdings PLC), signed an agreement on 13th Oct'26 with the Board of Investment of Sri Lanka. The JV will establish a pharmaceutical manufacturing facility across nearly four acres in Horana, Sri Lanka, with a phased investment exceeding USD 20 million. Phase one will produce oral solid dosage forms for the Sri Lankan market, with commercial operations scheduled to begin in 2028, subject to regulatory approvals.
Original exchange filing (PDF)
More announcements from Zydus Lifesciences Ltd
- Press Release 路 14 Nov 2026
- Completion of transaction 路 12 Nov 2026
- Transcript of the post results earnings call held on November 4, 2026. 路 07 Nov 2026
- Press Release 路 07 Nov 2026
- The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Life Insurance Corporation of India 路 06 Nov 2026
- Investor Conference 路 06 Nov 2026
- Audio recording of the Company's Investor Call 路 05 Nov 2026
- Press Release 路 04 Nov 2026
